MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2020 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
7.55 M |
Market Cap[1] |
$ 200 M |
EBITDA (LTM) |
$ -22.7 M |
P/E (LTM) |
-8.25 |
P/S (LTM) |
1.83 |
EPS (LTM) |
-2.76 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
DarioHealth Corp.
DRIO
|
$ 6.98 | 1.51 % | $ 27.8 M | Nasdaq Capital Market |  Israel |
 |
Charles River Laboratories International
CRL
|
$ 293.35 | 0.54 % | $ 14.5 B | NYSE,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 163.58 | 2.34 % | $ 12.8 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Brainsway Ltd.
BWAY
|
$ 14.51 | 1.61 % | $ 493 M | Nasdaq Global Select Market | Israel |
 |
Celcuity
CELC
|
$ 96.43 | 0.24 % | $ 4.51 B | Nasdaq Global Select Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 356.23 | 0.66 % | $ 28 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 3.23 | 1.57 % | $ 299 M | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
ENDRA Life Sciences
NDRA
|
$ 5.68 | 22.58 % | $ 4.47 M | Nasdaq Global Select Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
National Research Corporation
NRC
|
$ 21.25 | 6.2 % | $ 476 M | Nasdaq Global Select Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
OPKO Health
OPK
|
$ 1.61 | 11.18 % | $ 1.21 B | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.3 | 3.13 % | $ 390 M | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 16.83 | 0.6 % | $ 1.5 B | Nasdaq Global Select Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 239.4 | 2.07 % | $ 26.6 B | NYSE,SPB | USA |
 |
DexCom
DXCM
|
$ 89.71 | 0.02 % | $ 35 B | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.05 | 0.64 % | $ 99 K | Nasdaq Capital Market | USA |
 |
Neuronetics
STIM
|
$ 2.72 | 0.18 % | $ 179 M | Nasdaq Global Select Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | Schweiz |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | Britain |
 |
Interpace Biosciences
IDXG
|
$ 1.45 | 2.11 % | $ 6.41 M | Nasdaq Global Select Market | USA |
 |
IQVIA Holdings
IQV
|
$ 271.62 | 2.95 % | $ 46.7 B | NYSE,SPB | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |
 |
Quidel Corporation
QDEL
|
$ 13.93 | 1.45 % | $ 587 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.